Sharekhan

BUY NOW Buy Titan Biotech Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Titan Biotech Ltd

Tue 16/06/2026,13:23:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 452.50

Previous Close

₹ 448.30

Volume

11082

Mkt Cap ( Rs. Cr)

₹1849.62

High

₹ 456.00

Low

₹ 445.00

52 Week High

₹ 555.65

52 Week Low

₹ 74.73

Book Value Per Share

₹ 43.94

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Titan Biotech Ltd

Your Vote -

Buy

53.85%

Hold

19.23%

Sell

26.92%

53.85%

26 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Titan Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Titan Biotech Q4 net profit jumps 74.01% at Rs 6.56 cr

30 May 2026, 4:40PM The company reported standalone net profit of Rs 6.56 crore for the quarter ended March 31, 2026 as compared to Rs 3.77 crore in the same period last
Titan Biotech - Re-Appointment Of Cost Auditor For Financial Year 2026-2027

30 May 2026, 4:05PM Intimation for re-appointment of Cost Auditor of the Company
Titan Biotech - Corporate Action-Board to consider Dividend

30 May 2026, 4:00PM The Board of Director of the Company has recommended a dividend of Rs. 0.50 paisa per Equity Share
Titan Biotech - Result_Audited Financial Results For The Quarter And Year Ended March 31, 2026

30 May 2026, 3:56PM Audited Financial Results for March 31, 2026
Titan Biotech - Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May, 202

30 May 2026, 3:49PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Dir
Titan Biotech - Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Co

20 May 2026, 5:00PM Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and ap
Titan Biotech - Intimation Regarding Second 100 Days Campaign - 'Saksham Niveshak'

6 May 2026, 6:00PM Second 100 days Campaign under Saksham Niveshak Yojna
Titan Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

6 May 2026, 11:32AM Newspaper publication regarding special window for re-lodgement of transfer request and dematerialisation of physical shares.
Titan Biotech - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

28 Apr 2026, 4:00PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
Titan Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

23 Apr 2026, 12:04PM Newspaper advertisement for Loss of Share Certificate
Titan Biotech has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

18 Apr 2026, 11:50AM As of March 2026, 55.78% is owned by Indian Promoters and 44.22% by Public. <p align=justify> Top five Promoters holding highest number of shares of T
Titan Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

6 Apr 2026, 3:58PM Newspaper advertisement for Loss of Share Certificate
Titan Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

4 Apr 2026, 5:13PM Compliance Certificate under Regn 74(5) of SEBI (DP) Regulations, 2018

Key fundamentals

Evaluate the intrinsic value of Titan Biotech Ltd stock

Name	March-26	March-25	March-24	March-23	March-22
Assets	174.5122	147.2358	135.613	113.0902	92.0429
Liabilities	174.5122	147.2358	135.613	113.0902	92.0429
Equity	8.2637	8.2637	8.2637	8.2637	8.2637
Gross Profit	38.6035	25.4264	34.2814	29.5192	31.1807
Net Profit	27.4472	18.2711	23.6632	21.0248	21.6843
Cash From Operating Activities	30.4208	20.1233	21.1463	21.1783	21.9524
NPM(%)	13.31	11.67	14.42	14.6	17.55
Revenue	206.1903	156.4508	164.0721	143.9993	123.5488
Expenses	167.5868	131.0244	129.7907	114.4801	92.3681
ROE(%)	15.11	10.06	13.03	11.58	11.94

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2024	2025	Equity Share	10.00	8.26	8263700.00	10	8.26
2023	2024	Equity Share	10.00	8.26	8263700.00	10	8.26
2022	2023	Equity Share	10.00	8.26	8263700.00	10	8.26
2021	2022	Equity Share	10.00	8.26	8263700.00	10	8.26
2020	2021	Equity Share	10.00	8.26	8263700.00	10	8.26
2019	2020	Equity Share	10.00	8.26	8263700.00	10	8.26
2018	2019	Equity Share	10.00	8.26	8263700.00	10	8.26
2017	2018	Equity Share	10.00	7.74	7738700.00	10	7.74
2016	2017	Equity Share	10.00	7.74	7738700.00	10	7.74
2015	2016	Equity Share	10.00	7.74	7738700.00	10	7.74
2014	2015	Equity Share	10.00	7.74	7738700.00	10	7.74
2013	2014	Equity Share	8.00	7.04	7038700.00	10	7.04
2012	2013	Equity Share	8.00	7.04	7038700.00	10	7.04
2011	2012	Equity Share	8.00	7.04	7038700.00	10	7.04
2010	2011	Equity Share	8.00	5.54	5538700.00	10	5.54
2009	2010	Equity Share	6.00	5.54	5538700.00	10	5.54
2007	2008	Equity Share	6.00	5.54	5538700.00	10	5.54
2006	2007	Equity Share	6.00	5.54	5538700.00	10	5.54
2000	2002	Equity Share	6.00	5.54	5538700.00	10	5.54
1999	2000	Equity Share	6.00	5.54	5538700.00	10	5.54
1996	1997	Equity Share	6.00	5.54	5538700.00	10	5.54
1994	1996	Equity Share	6.00	5.54	5538700.00	10	5.54
1993	1994	Equity Share	4.00	0.58	580570.00	10	0.58

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Titan Biotech Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
GRM Overseas Ltd	92.40	5.18	25.68	2689.80	179.39	0.00
Jain Irrigation Systems Ltd	31.26	-0.92	0.00	30982.91	-17.22	0.00
Tierra Agrotech Ltd	39.74	-0.72	0.00	2940.57	-7.60	0.00
Kohinoor Foods Ltd	25.55	-0.54	1.19	1661.92	217.58	0.00

Company Info

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Read More

Parent Organisation

Titan Biotech Ltd.

Founded

18/02/1992

Managing Director

Mr.Naresh Kumar Singla

NSE Symbol

FAQ

The current price of Titan Biotech Ltd is ₹ 447.65.

The 52-week high for Titan Biotech Ltd is

The market capitalization of Titan Biotech Ltd is currently ₹ 1849.62. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Titan Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Titan Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Titan Biotech Ltd shares.

The CEO of Titan Biotech Ltd is Mr.Naresh Kumar Singla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT